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TRANSVALVULAR TECHNIQUE FOR IMPLANTATION OF A MITRAL VALVE HOMOGRAFT 
José M. Revuelta, MD, José M. Bemal, MD, and José M. Rabasa, MD, Santander, Spain 
The first attempts to replace atrioventricular valves with 
total or partial mitral valve homografts were performed 
on dogs in 1954. Further clinical and experimental studies 
were unsatisfactory, and homograft replacement of the 
mitral valve was eventually abandoned. By contrast, aortic 
homografts have been widely considered the best substi- 
tutes for aortic valve replacement since the first successful 
implantation of an aortic valve homograft was reported by 
Ross I in 1962. Experience in the field of aortic homografts 
during the past 30 years, increasing availability of ho- 
mograft valves resulting from the development of heart 
transplantation programs, and the fact that prosthetic 
mitral valve replacement and reconstructive operations 
seem to have reached the ceiling have contributed to the 
resurgence of interest in mitral valve homografts. Major 
impediments related to technical dilficulties remain in the 
widespread use of homograft replacement of the mitral 
valve. Reimplanted papillary muscles are subjected to 
systolic pressure of the left ventricle, with risk of dehis- 
cence. Tailoring of the circumferential size of the graft 
and length of ehordae tendinae may be another surgical 
problem. We describe a technique of transvalvular im- 
plantation of a cryopreserved mitral homograft leaving 
the whole mitral valve apparatus of the recipient. 
A 64-year-old man with a history of essential hyperten- 
sion was hospitalized because of progressive xertional 
dyspnea nd pulmonary edema. Transthoracic echocardi- 
ography revealed severe mitral regurgitation with pro- 
lapse of the posterior leaflet caused by rupture of the main 
chordae with dilatation of the left ventricle and giant left 
atrium. Perioperative transesophageal echocardiography 
and examination of the mitral valve confirmed the diag- 
nosis, demonstrating severe valvular lesions: rupture of 
the main chordae, prolapse of the posterior and anterior 
leaflets, and annular dilatation. A cryopreserved (3 
months) mitral homograft, 31 mm in diameter, from a 
heart explanted during a transplantation was used for 
mitral valve replacement. The mitral valve apparatus was 
not resected, and native papillary muscles were used as 
reference points for adjustment of the length of the graft's 
papillary muscles. Each papillary muscle was then flxed to 
the corresponding recipient point with two terminolateral 
sutures (3-0 polypropylene) with pledgets (Fig. 1). Two 
reference sutures were placed in both trigones; these were 
used as a guide when the graft anulus was fixed to the 
recipient anulus. A reference suture was also placed in the 
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middle part of the posterior leaflet. The mitral valve was 
preserved, and implantation of the homograft around the 
anulus was completed with a running suture (3-0 polypro- 
pylene). These sutures included the patient's anulus, the 
ffee edge of the native leaflet tissue, and the graft anulus. 
The annular suture was supported with a 31 mm Duran 
flexible annuloplasty ring (Medtronic Cardiovascular Sur- 
gery, Heart Valve Division, Minneapolis, Minn.). After 
discontinuation of cardiopulmonary b pass, transesopha- 
geal echocardiography showed proper functioning of the 
graft without prolapse and with an effective valve area of 
2.5 cm 2. Atrial fibrillation occurring after operation re- 
verted to sinus rhythm with amiodarone. The patient was 
discharged on the eighth postoperative day and was given 
antiplatelet therapy for 3 months. At present, 10 months 
after operation, the patient is free of symptoms. Transtho- 
racic echocardiography showed mild mitral incompetence 
caused by prolapse of the anterior leaflet with a normal eft 
ventricle. 
Technical difficulties in the implantation of the subval- 
vular apparatus, proper measurement of the graft, and 
early dehiscence of the reimplanted papillary muscles have 
been major impediments in the widespread use of human 
mitral valves. In our opinion, the intertrigonal distance, 
rather than the intercommissural distance, is the most 
suitable measurement for determining the size of 
the homograft. 2 The site of implantation of the heads of the 
graft's papillary muscles is an important--and still unre- 
solved--technical aspect. Knowledge gained through recon- 
structive operations of the mitral valve allow use in practice 
of the experience acquired in chordal shortening or replace- 
ment. On the other hand, native chordae tendinae can be 
used as reference points during implantation of the ho- 
mograft when the whole mitral valve apparatus i preserved. 
Dehiscence of the reimplanted subvalvular apparatus i
the main postoperative failure in mitral valve homograft- 
ing. In 1985, Sievers and colleagues 3 reported the cases of 
three patients who needed urgent reoperation for severe 
mitral insutticiency caused by ruptured chordae (two 
cases) and ruptured graft papillary muscle (one case) at 2, 
9, and 44 months after mitral homograft replacement. 
Acar and coworkers 2 have used glutaraldehyde fixation in 
the papillary muscles of the homograft to minimize the 
risk of necrosis. Chemical f~xation with glutaraldehyde, 
however, prevents cellular integration of the homograft 
which is the main advantage of the clinical use of human 
valves. Perhaps for this reason, chemical fixation of the 
graft has been recently abandoned. In our experience, 
implantation of papillary muscles has been carried out 
successfully, first in a sheep model 4 and subsequently in
human beings. 5 Although papillary muscles have been 
inserted in a laterolateral position, 2 terminolateral im- 
plantation seems to be more appropriate because the apex 
of the papillary muscle (site of insertion of the chordae 
tendineae) is the area of the greatest strength to support 
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Fig. 1. Mitral homograft implantation preserving the entire native valve apparatus. Notice the termino- 
lateral implantation of the papillary muscle. 
the tension of the sutures. On the other hand, preserva- 
tion of the native valvular apparatus aids in diminishing 
tension on the homograft. Ring annuloplasty ensures that 
annular reduction is carried out on a resistant issue, 
reducing suture tension on the graft anulus, which may 
cause tearing and perivalvular dehiscence. 
Although the interest in homograft replacement of 
atrioventricular valves has resumed in recent years, im- 
plantation of a mitral valve homograft is a complex 
operation that entails a risk of dehiscence of the reim- 
planted papillary muscles. Technical advances may con- 
tribute to expand the clinical use of mitral valve ho- 
mografts in selected patients. Long-term stability of the 
results obtained, however, remains to be confirmed. 
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